IPG Photonics Corporation — Q2 2019 Form 10-Q
Reporting period: Three and six months ended June 30, 2019. Financial statements are unaudited. IPG develops and manufactures fiber lasers, amplifiers, diode lasers, and laser and non-laser systems, primarily for materials processing applications, and sells globally.
Financial performance
Amounts below are in millions of dollars, except per-share data and percentages.
| Metric | Q2 2019 | Q2 2018 | Six months 2019 | Six months 2018 |
|---|---|---|---|---|
| Net sales | $363.8 | $413.6 | $678.8 | $773.5 |
| Gross profit | $180.2 | $235.0 | $329.1 | $438.3 |
| Gross margin | 49.5% | 56.8% | 48.5% | 56.7% |
| Operating income | $91.1 | $162.4 | $159.4 | $303.5 |
| Net income attributable to IPG | $72.3 | $121.6 | $127.4 | $228.0 |
| Diluted EPS | $1.34 | $2.21 | $2.36 | $4.14 |
- Q2 sales fell 12.1% year over year; six-month sales fell 12.2%. Materials processing accounted for 95.0% of Q2 sales and 95.3% of six-month sales.
- Management attributed weaker results principally to lower average selling prices, softer demand in key markets, higher inventory provisions and reduced absorption of manufacturing costs at lower sales volumes. Genesis Systems’ lower-margin systems mix reduced gross margin by 1.9 percentage points in Q2 and 2.1 points for the six-month period.
- Q2 sales of high-power CW lasers fell 19.8%; medium- and low-power CW laser sales fell 50.2%. Laser and non-laser systems sales rose 193.3%, largely reflecting Genesis. China sales were $163.6 million in Q2, down from $203.0 million.
- Operating expenses rose to $89.1 million in Q2 from $72.6 million. Sales and marketing, R&D, and G&A expenses all increased; foreign-exchange losses were $5.1 million versus $2.1 million in Q2 2018. The six-month foreign-exchange result was a $6.7 million loss versus a $3.2 million gain.
Cash flow, balance sheet and liquidity
- Six-month operating cash flow was $101.8 million, down from $208.6 million. Investing used $106.3 million, including $86.5 million of capital expenditures and $15.1 million for acquisitions; financing used $4.1 million. Cash and cash equivalents declined $14.4 million from year-end.
- At June 30, cash and cash equivalents were $530.0 million and short-term investments were $512.8 million. Total debt was $43.6 million, including $3.7 million current. Management reported $106.7 million of available credit facilities and stated that the company complied with its financial covenants.
- Total assets were $2.74 billion, total liabilities $370.1 million, and equity $2.37 billion. Inventory was $426.0 million, up from $403.6 million at year-end; six-month inventory provisions were approximately $12.6 million in the notes.
- One customer represented 11.6% of six-month sales and 39.2% of net accounts receivable at June 30, compared with 13.0% of six-month sales and 24.7% of receivables at December 31, 2018.
Outlook, changes and notable items
- Management forecast 2019 capital expenditures of $170–$180 million, primarily to expand facilities and equipment capacity. It gave no specific revenue or earnings guidance in the supplied filing text.
- Management described continued investment in R&D, sales and marketing, manufacturing capacity, and potential acquisitions. It cautioned that lower selling prices and further cost reductions needed to support gross margins.
- IPG acquired Genesis in December 2018 and acquired Padtec’s submarine networks division in Q1 2019 for $19.6 million; the Padtec purchase-price allocation remained preliminary. Acquisitions contributed to higher goodwill, intangible assets and expenses.
- The company adopted the new lease standard on January 1, 2019. At June 30, it reported $27.1 million of operating lease right-of-use assets and $27.0 million of lease liabilities.
- Key stated risks include cyclical demand and customer capital spending, intensified competition and pricing pressure, China and trade-policy exposure, foreign-exchange movements, customer concentration, inventory and fixed-cost exposure, and export controls and sanctions affecting international operations, including Russia. The filing reported no legal proceedings that management expected to have a material financial effect and no material developments in previously reported proceedings.
Important facts for investors to verify
- Whether demand and pricing in materials processing, particularly in China and Europe, continue to weaken or stabilize.
- Whether gross margins recover as selling prices, inventory provisions, production utilization and the Genesis systems mix evolve.
- Whether inventory and receivables convert to cash as expected, given the inventory increase and major-customer receivable concentration.
- Whether 2019 capital spending remains within the stated $170–$180 million range and supports utilization and returns.
- Whether acquisition integration, foreign-exchange exposure, trade restrictions and export-control risks materially affect future results.